KLF5 and hypertrophic cardiomyopathy: To circumvent the hypertrophic cardiomyopathy associated with Klf5 ablation in the systemic modulation experiment in the heart, we adopted an alternative strategy to specifically assess the molecular consequences of Klf5 loss in skeletal muscle.